↓ Skip to main content

Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer

Overview of attention for article published in Advances in Therapy, January 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
56 Mendeley
Title
Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
Published in
Advances in Therapy, January 2014
DOI 10.1007/s12325-014-0092-1
Pubmed ID
Authors

Sebastian Christoph Schmid, Alexander Geith, Alena Böker, Robert Tauber, Anna Katharina Seitz, Markus Kuczyk, Christoph von Klot, Jürgen Erich Gschwend, Axel Stuart Merseburger, Margitta Retz

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 2%
Italy 1 2%
Switzerland 1 2%
Unknown 53 95%

Demographic breakdown

Readers by professional status Count As %
Other 10 18%
Researcher 10 18%
Student > Ph. D. Student 7 13%
Student > Master 6 11%
Student > Bachelor 3 5%
Other 11 20%
Unknown 9 16%
Readers by discipline Count As %
Medicine and Dentistry 30 54%
Pharmacology, Toxicology and Pharmaceutical Science 7 13%
Social Sciences 3 5%
Engineering 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 4 7%
Unknown 9 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2016.
All research outputs
#7,512,050
of 22,947,506 outputs
Outputs from Advances in Therapy
#726
of 2,369 outputs
Outputs of similar age
#92,447
of 306,121 outputs
Outputs of similar age from Advances in Therapy
#9
of 18 outputs
Altmetric has tracked 22,947,506 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,369 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 306,121 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.